COBACTAN LA 7.5% W/V SUSPENSION FOR INJECTION FOR SWINE

Ülke: İrlanda

Dil: İngilizce

Kaynak: HPRA (Health Products Regulatory Authority)

Aktif bileşen:

CEFQUINOME (AS SULFATE)

Mevcut itibaren:

Intervet Ireland Limited

ATC kodu:

QJ01DE90

INN (International Adı):

CEFQUINOME (AS SULFATE)

Doz:

7.5 %w/v

Farmasötik formu:

Suspension for Injection

Reçete türü:

POM

Terapötik grubu:

Porcine

Terapötik alanı:

Cefquinome

Terapötik endikasyonlar:

Antibacterial

Yetkilendirme durumu:

Authorised

Yetkilendirme tarihi:

2012-06-15

Ürün özellikleri

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Cobactan LA 7.5% w/v suspension for injection for swine
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Cefquinome (as sulfate)
75 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Suspension for injection
White to off-white resuspendable suspension
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of swine respiratory disease (SRD) associated with_
Actinobacillus pleuropneumoniae, Haemophilus_
_parasuis_ and_ Pasteurella multocida_ sensitive to cefquinome.
4.3 CONTRAINDICATIONS
Do not use in animals which are known to be hypersensitive to
cephalosporin antibiotics or to other
-lactam
antibiotics, or to any of the excipients.
Do not use in poultry (including eggs) due to risk of spread of
antimicrobial resistance to humans.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
In food borne pathogens, co-resistance can occur for various
antimicrobial substances including aminoglycosides,
sulphonamides and trimethoprim compounds, chloramphenicol,
ciprofloxacin, gentamicin and tetracycline.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_4_
_/_
_0_
_3_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_4_
_8_
_0_
_2_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Cobactan LA 7.5% w/v suspension for injection fo